BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 2, 2019
Politics & Policy

Part D beneficiaries hit hardest under 2019 price hikes

BioCentury | Aug 8, 2016
Clinical News

Viberzi eluxadoline regulatory update

BioCentury | Jul 22, 2016
Company News

CHMP recommendations include Truvada for PrEP

BioCentury | Jan 18, 2016
Company News

Allergan, Ironwood sales and marketing update

BioCentury | Sep 28, 2015
Company News

Allergan, Ironwood deal

BioCentury | Jun 1, 2015
Clinical News

Viberzi eluxadoline regulatory update

BioCentury | May 28, 2015
Company News

FDA approves pair of IBS therapies

BioCentury | Sep 8, 2014
Clinical News

Eluxadoline regulatory update

BioCentury | Sep 3, 2014
Company News

Priority Review for Actavis' eluxadoline

Items per page:
1 - 10 of 21